Sato Nobuaki

Department of Breast Oncology Niigata Cancer Center Hospital

关注

立即认领

关注

立即认领

基本信息

浏览量：90

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 131 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Increasing Survivors of Anthracycline-related Cardiomyopathy with Breast Cancer in Trastuzumab Era: Thirty-one-Year Trends in a Japanese Community

Mitsuhiro Watanabe,Shinya Fujiki,Yuji Okura,Chie Toshikawa,Mayuko Ikarashi,Chizuko Kanbayashi,Koji Kaneko,Akira Kikuchi,Eiko Sakata,Keiichi Tsuchida,Kazuyuki Ozaki,Kazuki Moro,Naoki Kubota,Takeshi Kashimura,Masato Moriyama,Nobuaki Sato,Naohito Tanabe,Yu Koyama,Toshifumi Wakai,Yasuo Saijo,Takayuki Inomata

BREAST CANCERno. 6 (2024): 1080-1091

引用0浏览0WOS引用

TP53 Signature Predicts Pathological Complete Response after Neoadjuvant Chemotherapy for Breast Cancer: Observational and Confirmational Study Using Prospective Study Cohorts

Shin Takahashi,Nobuaki Sato, Kouji Kaneko,Norikazu Masuda,Masaaki Kawai,Hisashi Hirakawa,Tadashi Nomizu,Hiroji Iwata,Ai Ueda,Takashi Ishikawa,Hiroko Bando,Yuka Inoue,Takayuki Ueno,Shinji Ohno,Makoto Kubo,Hideko Yamauchi,Masahiro Okamoto,Eriko Tokunaga,Shunji Kamigaki,Kenjiro Aogi,Hideaki Komatsu,Masahiro Kitada,Yasuaki Uemoto,Tatsuya Toyama,Yutaka Yamamoto,Toshinari Yamashita,Takehiro Yanagawa,Hiroko Yamashita,Yoshiaki Matsumoto,Masakazu Toi,Minoru Miyashita,Takanori Ishida,Fumiyoshi Fujishima,Satoko Sato,Takuhiro Yamaguchi,Fumiaki Takahashi,Chikashi Ishioka

TRANSLATIONAL ONCOLOGY (2024)

引用0浏览0WOS引用

Fulvestrant with or Without Anti‐her2 Therapy in Patients in a Postmenopausal Hormonal State and with ER‐positive HER2‐positive Advanced or Metastatic Breast Cancer: A Subgroup Analysis of Data from the Safari Study (JBCRG‐C06)

Misato Masuyama,Norikazu Masuda,Hidetoshi Kawaguchi,Yutaka Yamamoto,Shigehira Saji,Takahiro Nakayama,Kenjiro Aogi,Keisei Anan,Shoichiro Ohtani,Nobuaki Sato,Toshimi Takano,Eriko Tokunaga,Seigo Nakamura,Yoshie Hasegawa,Masaya Hattori,Tomomi Fujisawa,Satoshi Morita,Miki Yamaguchi,Toshinari Yamashita,Daisuke Yotsumoto,Masakazu Toi,Shinji Ohno

CANCER MEDICINE（2023）

引用1浏览0WOS引用

Adjuvant S-1 Plus Endocrine Therapy for Estrogen Receptor-Positive, HER2-negative, Primary Breast Cancer: Updated Overall Survival Analysis from the POTENT Trial

Masahiro Takada,Shigehira Saji,Takayuki Ueno,Norikazu Masuda,Hiroshi Ishiguro,Takanori Ishida,Toshiaki Saeki,Shigeru Imoto,Shinji Ohno,Hiroji Iwata,Tomoharu Sugie,Kenjiro Aogi,Hirofumi Mukai,Shin Takayama,Nobuaki Sato,Yuichiro Kai,Masahiro Kitada,Rikiya Nakamura,Yutaka Matsuyama,Masakazu Toi

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Retrospective Study Using Database for the Effectiveness of Medroxyprogesterone Acetate in Patients with ER-positive/HER2-negative Postmenopausal Advanced Breast Cancer: an Additional Analysis of the JBCRG-C06 Safari Study

Kaho Utsunomiya,Hidetoshi Kawaguchi,Yutaka Yamamoto,Shigehira Saji,Norikazu Masuda,Takahiro Nakayama,Kenjiro Aogi,Keisei Anan,Shoichiro Ohtani,Nobuaki Sato,Toshimi Takano,Eriko Tokunaga,Seigo Nakamura,Yoshie Hasegawa,Masaya Hattori,Tomomi Fujisawa,Satoshi Morita,Miki Yamaguchi,Toshinari Yamashita,Daisuke Yotsumoto,Masakazu Toi,Shinji Ohno

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Abstract P1-01-05: Adjuvant S-1 Plus Endocrine Therapy for Estrogen Receptor-Positive, HER2-negative, Primary Breast Cancer: Updated Overall Survival Analysis from the POTENT Trial

Cancer Research（2023）

引用0浏览0引用

Abstract P2-03-15: Retrospective Study Using Database for the Effectiveness of Medroxyprogesterone Acetate in Patients with ER-positive/HER2-negative Postmenopausal Advanced Breast Cancer: an Additional Analysis of the JBCRG-C06 Safari Study

Cancer Researchno. 5_Supplement (2023): P2-03

引用0浏览0引用

Factors Associated with Overall Survival after Recurrence in Patients with ER-positive/HER2-negative Postmenopausal Breast Cancer: an Ad Hoc Analysis of the JBCRG-C06 Safari Study

Hidetoshi Kawaguchi,Yutaka Yamamoto,Shigehira Saji,Norikazu Masuda,Takahiro Nakayama,Kenjiro Aogi,Keisei Anan,Yoshinori Ito,Shoichiro Ohtani,Nobuaki Sato,Toshimi Takano,Eriko Tokunaga,Seigo Nakamura,Yoshie Hasegawa,Masaya Hattori,Tomomi Fujisawa,Satoshi Morita,Miki Yamaguchi,Hiroko Yamashita,Toshinari Yamashita,Daisuke Yotsumoto,Masakazu Toi,Shinji Ohno

Japanese Journal of Clinical Oncology（2022）

引用2浏览0WOS引用

Correction To: Validation of a Nuclear Grading System for Resected Stage I–IIIA, High-Risk, Node-Negative Invasive Breast Carcinoma in the N·SAS-BC 01 Trial

Tsuda Hitoshi,Kurosumi Masafumi,Akiyama Futoshi,Ohno Shinji,Saji Shigehira,Masuda Norikazu,Shimomura Akihiko,Sato Nobuaki,Takao Shintaro,Ohsumi Shozo,Tokuda Yutaka,Inaji Hideo,Watanabe Toru

Breast cancer（2022）

引用1浏览0WOS引用

A Prediction Model for Early Systemic Recurrence in Breast Cancer Using a Molecular Diagnostic Analysis of Sentinel Lymph Nodes: A Large-Scale, Multicenter Cohort Study

Tomo Osako,Masaaki Matsuura,Daisuke Yotsumoto,Shin Takayama,Koji Kaneko,Mina Takahashi,Kenzo Shimazu,Katsuhide Yoshidome,Kazuya Kuraoka,Masayuki Itakura,Mayumi Tani,Takashi Ishikawa,Yasuyo Ohi,Takayuki Kinoshita,Nobuaki Sato,Masahiko Tsujimoto,Seigo Nakamura,Hitoshi Tsuda,Shinzaburo Noguchi,Futoshi Akiyama

Cancer（2022）

引用7浏览0WOS引用

加载更多

作者统计

#Papers: 132

#Citation: 1570

H-Index: 24

G-Index: 35

Sociability: 6

Diversity: 3

Activity: 33

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn